{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:27:51Z","timestamp":1780597671078,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T00:00:00Z","timestamp":1549065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12944-019-0979-6","type":"journal-article","created":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T07:04:03Z","timestamp":1549091043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Assessment of the LDL-C\/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation"],"prefix":"10.1186","volume":"18","author":[{"given":"Zhixiong","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunren","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5178-3664","authenticated-orcid":false,"given":"Pingsen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,2]]},"reference":[{"key":"979_CR1","doi-asserted-by":"crossref","unstructured":"Li H, Ge J. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117\u2013171.","DOI":"10.1016\/S0140-6736(14)61682-2"},{"key":"979_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ijcard.2015.06.170","volume":"6","author":"H Li","year":"2015","unstructured":"Li H, Ge J. Cardiovascular diseases in China: current status and future perspectives. Int J Cardiol Heart Vasc. 2015;6:25\u201331.","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"35","key":"979_CR3","first-page":"2541","volume":"2014","author":"S Windecker","year":"2014","unstructured":"Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. ESC\/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;2014(35):2541\u2013619.","journal-title":"Eur Heart J"},{"key":"979_CR4","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1007\/s00380-015-0746-1","volume":"31","author":"R Naito","year":"2016","unstructured":"Naito R, Miyauchi K, Konishi H, Tsuboi S, Ogita M, Dohi T, et al. Comparing mortality between coronary artery bypass grafting and percutaneous coronary intervention with drug-eluting stents in elderly with diabetes and multivessel coronary disease. Heart Vessel. 2016;31:1424\u20139.","journal-title":"Heart Vessel"},{"key":"979_CR5","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1161\/CIRCULATIONAHA.107.688416","volume":"115","author":"WK Laskey","year":"2007","unstructured":"Laskey WK, Yancy CW, Maisel WH. Thrombosis in coronary drug-eluting stents: report from the meeting of the circulatory system medical devices advisory panel of the Food and Drug Administration Center for devices and radiologic health, December 7-8. 2006. Circulation. 2007;115:2352\u20137.","journal-title":"Circulation"},{"key":"979_CR6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0140-6736(04)16850-5","volume":"364","author":"MN Babapulle","year":"2004","unstructured":"Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet. 2004;364:583\u201391.","journal-title":"Lancet"},{"key":"979_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s00380-013-0339-9","volume":"29","author":"H Kaneko","year":"2014","unstructured":"Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, et al. Impact of aging on the clinical outcomes of Japanese patients with coronary artery disease after percutaneous coronary intervention. Heart Vessel. 2014;29:156\u201364.","journal-title":"Heart Vessel"},{"key":"979_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJMoa0808227","volume":"360","author":"T Simon","year":"2009","unstructured":"Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Meneveau N, et al. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med. 2009;360:363\u201375.","journal-title":"N Engl J Med"},{"key":"979_CR9","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1093\/eurheartj\/eht142","volume":"34","author":"JA Beckman","year":"2013","unstructured":"Beckman JA, Paneni F, Cosentino F, Creager MA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J. 2013;34:2444\u201352.","journal-title":"Eur Heart J"},{"key":"979_CR10","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/hrt.2005.075960","volume":"92","author":"SJ Hong","year":"2006","unstructured":"Hong SJ, Kim MH, Ahn TH, Ahn YK, Bae JH, Shim WJ, et al. Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes. Heart. 2006;92:1119\u201324.","journal-title":"Heart"},{"key":"979_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00380-013-0330-5","volume":"29","author":"M Ogita","year":"2014","unstructured":"Ogita M, Miyauchi K, Miyazaki T, Naito R, Konishi H, Tsuboi S, et al. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol. Heart Vessel. 2014;29:35\u201341.","journal-title":"Heart Vessel"},{"key":"979_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.amjcard.2015.01.009","volume":"115","author":"U Landes","year":"2015","unstructured":"Landes U, Kornowski R, Assali A, Vaknin-Assa H, Greenberg G, Lev EI, et al. Predictors of long term outcomes in 11,441 consecutive patients following percutaneous coronary interventions. Am J Cardiol. 2015;115:855\u20139.","journal-title":"Am J Cardiol"},{"key":"979_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jacc.2009.07.057","volume":"55","author":"BJ Arsenault","year":"2009","unstructured":"Arsenault BJ, Rana JS, Stroes ES, Despres JP, Shah PK, Kastelein JJ, et al. Beyond low-density lipoprotein cholesterol respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol\/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol. 2009;55:35\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"979_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.5812\/ircmj.3370","volume":"15","author":"SK Hosseini","year":"2013","unstructured":"Hosseini SK, Tahvildari M, Alemzadeh Ansari MJ, Nakhjavani M, Esteghamati A, Lotfi Tokaldany M. Clinical lipid control success rate before and after percutaneous coronary intervention in Iran; a single center study. Iran Red Crescent Med J. 2013;15:467\u201372.","journal-title":"Iran Red Crescent Med J"},{"key":"979_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12944-017-0636-x","volume":"16","author":"Z Zhong","year":"2017","unstructured":"Zhong Z, Liu J, Li B, Li C, Liu Z, Yang M, et al. Serum lipid profiles in patients with acute myocardial infarction in Hakka population in southern China. Lipids Health Dis. 2017;16:246.","journal-title":"Lipids Health Dis"},{"key":"979_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00380-016-0835-9","volume":"32","author":"H Wada","year":"2017","unstructured":"Wada H, Ogita M, Miyauchi K, Shitara J, Endo H, Doi S, et al. Impact of gender difference on long-term outcomes of percutaneous coronary intervention for coronary artery disease in patients under statin treatment. Heart Vessel. 2017;32:16\u201321.","journal-title":"Heart Vessel"},{"key":"979_CR17","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00392-016-0991-z","volume":"105","author":"U Laufs","year":"2016","unstructured":"Laufs U, Karmann B, Pittrow D. Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk. Clin Res Cardiol. 2016;105:783\u201390.","journal-title":"Clin Res Cardiol"},{"key":"979_CR18","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.12659\/MSM.907400","volume":"24","author":"Z Zhong","year":"2018","unstructured":"Zhong Z, Liu J, Zhang Q, Zhong W, Li B, Li C, et al. Relationship between preoperative low-density lipoprotein cholesterol and Periprocedural myocardial injury in patients following elective percutaneous coronary intervention in southern China. Med Sci Monit. 2018;24:4154\u201361.","journal-title":"Med Sci Monit"},{"key":"979_CR19","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"C Baigent","year":"2010","unstructured":"Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670\u201381.","journal-title":"Lancet"},{"key":"979_CR20","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1093\/eurheartj\/ehp183","volume":"30","author":"KJ Sattler","year":"2009","unstructured":"Sattler KJ, Herrmann J, Yun S, Lehmann N, Wang Z, Heusch G, et al. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention. Eur Heart J. 2009;30:1894\u2013902.","journal-title":"Eur Heart J"},{"key":"979_CR21","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1136\/hrt.2011.225466","volume":"97","author":"SM Seo","year":"2011","unstructured":"Seo SM, Choo EH, Koh YS, Park MW, Shin DI, Choi YS, et al. High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention. Heart. 2011;97:1943\u201350.","journal-title":"Heart"},{"key":"979_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2169\/internalmedicine.53.1438","volume":"53","author":"A Endo","year":"2014","unstructured":"Endo A, Yoshida Y, Kageshima K, Sato H, Suga T, Nasu H, et al. Contributors to newly developed coronary artery disease in patients with a previous history of percutaneous coronary intervention beyond the early phase of restenosis. Intern Med. 2014;53:819\u201328.","journal-title":"Intern Med"},{"key":"979_CR23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1253\/circj.CJ-10-0258","volume":"75","author":"I Matsumoto","year":"2011","unstructured":"Matsumoto I, Miyake Y, Mizukawa M, Takagi Y. Impact of low-density lipoprotein cholesterol\/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention. Circ J. 2011;75:905\u201310.","journal-title":"Circ J"},{"key":"979_CR24","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.111.060871","volume":"125","author":"G Ndrepepa","year":"2012","unstructured":"Ndrepepa G, Schuster T, Hadamitzky M, Byrne RA, Mehilli J, Neumann FJ, et al. Validation of the bleeding academic research consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention. Circulation. 2012;125:1424\u201331.","journal-title":"Circulation"},{"key":"979_CR25","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/eurheartj\/ehp041","volume":"30","author":"D Sibbing","year":"2009","unstructured":"Sibbing D, Stegherr J, Latz W, Koch W, Mehilli J, Dorrler K, et al. Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention. Eur Heart J. 2009;30:916\u201322.","journal-title":"Eur Heart J"},{"key":"979_CR26","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1056\/NEJMoa040583","volume":"350","author":"CP Cannon","year":"2004","unstructured":"Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495\u2013504.","journal-title":"N Engl J Med"},{"key":"979_CR27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1177\/0300060513476428","volume":"41","author":"K Miyauchi","year":"2013","unstructured":"Miyauchi K, Ray K. A review of statin use in patients with acute coronary syndrome in Western and Japanese populations. J Int Med Res. 2013;41:523\u201336.","journal-title":"J Int Med Res"},{"key":"979_CR28","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1161\/01.STR.0000226901.34927.10","volume":"37","author":"G Stoll","year":"2006","unstructured":"Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke. 2006;37:1923\u201332.","journal-title":"Stroke"},{"key":"979_CR29","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","volume":"295","author":"SE Nissen","year":"2006","unstructured":"Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006;295:1556\u201365.","journal-title":"JAMA"},{"key":"979_CR30","doi-asserted-by":"crossref","first-page":"e001412","DOI":"10.1161\/JAHA.114.001412","volume":"4","author":"XL Li","year":"2015","unstructured":"Li XL, Guo YL, Zhu CG, Xu RX, Qing P, Wu NQ, et al. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg\/dL. J Am Heart Assoc. 2015;4:e001412.","journal-title":"J Am Heart Assoc"},{"key":"979_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijcard.2010.04.052","volume":"146","author":"KH Yun","year":"2011","unstructured":"Yun KH, Oh SK, Rhee SJ, Yoo NJ, Kim NH, Jeong JW. 12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome. Int J Cardiol. 2011;146:68\u201372.","journal-title":"Int J Cardiol"},{"key":"979_CR32","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJMoa064278","volume":"357","author":"P Barter","year":"2007","unstructured":"Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 2007;357:1301\u201310.","journal-title":"N Engl J Med"},{"key":"979_CR33","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1253\/circj.CJ-11-0019","volume":"75","author":"N Kurebayashi","year":"2011","unstructured":"Kurebayashi N, Yoshikawa D, Ishii H, Sato B, Ando H, Okada T, et al. Impact of the low- to high-density lipoprotein cholesterol ratio on composition of angiographically ambiguous left main coronary artery plaque. Circ J. 2011;75:1960\u20137.","journal-title":"Circ J"},{"key":"979_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.297.5.499","volume":"297","author":"SJ Nicholls","year":"2007","unstructured":"Nicholls SJ, Tuzcu EM, Sipahi I, Grasso AW, Schoenhagen P, Hu T, et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA. 2007;297:499\u2013508.","journal-title":"JAMA"},{"key":"979_CR35","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMp0805758","volume":"359","author":"AB Goldfine","year":"2008","unstructured":"Goldfine AB. Assessing the cardiovascular safety of diabetes therapies. N Engl J Med. 2008;359:1092\u20135.","journal-title":"N Engl J Med"},{"key":"979_CR36","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.298.7.765","volume":"298","author":"SM Donahoe","year":"2007","unstructured":"Donahoe SM, Stewart GC, McCabe CH, Mohanavelu S, Murphy SA, Cannon CP, et al. Diabetes and mortality following acute coronary syndromes. JAMA. 2007;298:765\u201375.","journal-title":"JAMA"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-0979-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-019-0979-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-0979-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T09:12:04Z","timestamp":1662887524000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-019-0979-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,2]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["979"],"URL":"https:\/\/doi.org\/10.1186\/s12944-019-0979-6","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,2]]},"assertion":[{"value":"1 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"40"}}